Background Isolated distal deep vein thrombosis (IDDVT) is a common presentation of deep
vein thrombosis. There are limited data on the long-term risk of recurrence after IDDVT …

Background Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to
warfarin reduces the risk of post‐thrombotic syndrome (PTS) after deep vein thrombosis …

Abstract Objective The all-comer ClotTriever Outcomes registry assessed indicators of
thrombus chronicity in patients with acute, subacute, and chronic lower extremity deep vein …

Objective To compare thrombus removal and residual venous symptoms and signs of
disease following interventional treatment of iliofemoral deep vein thrombosis (DVT) with …

PURPOSE Patients with isolated distal deep vein thrombosis (DVT) have lower rates of
adverse outcomes (death, venous thromboembolism [VTE] recurrence or major bleeding) …

Background Residual venous obstruction (RVO) is considered a risk factor of recurrence
and possibly other clinical outcomes following deep vein thrombosis (DVT). Current …

Background Deep vein thrombosis (DVT) is a multifactorial disease with several outcomes,
but current classifications solely stratify it based on recurrence risk. Objectives We aimed to …

Abstract Objective Direct oral anticoagulants (DOACs) have been recommended for the
treatment of deep vein thrombosis (DVT). However, the benefits are uncertain for the …

Objective Venous stenting is performed increasingly for acute deep vein thrombosis (DVT)
and post-thrombotic syndrome (PTS) with good short term patency results, but long term …

Background We report in-hospital outcomes from the multicenter, prospective, single-arm
ClotTriever Outcomes (CLOUT) registry, which enrolled up to 500 patients with proximal …